Are there lawsuits involving Keytruda (pembrolizumab)?
Yes. Keytruda has been the subject of lawsuits in the U.S., most commonly tied to product-liability and other claims alleging harm from side effects, as well as disputes that are not limited to clinical outcomes (for example, litigation involving patents or other regulatory/business issues).
Some of the most visible Keytruda litigation has involved claims that the drug’s prescribing information or marketing did not adequately warn patients and doctors about serious risks, or that patients experienced severe injury after treatment.
What kinds of claims do Keytruda lawsuits usually involve?
Lawsuits involving cancer immunotherapies like Keytruda often focus on serious adverse events. Common categories seen in product-liability suits for immune checkpoint inhibitors include allegations related to:
- Immune-related side effects (including severe organ inflammation)
- Inadequate or delayed diagnosis/treatment guidance for immune toxicity
- Failure to provide adequate warnings in labeling
Exact allegations vary from case to case, and not every lawsuit will reach the same outcome.
Are there lawsuits over Keytruda patents or exclusivity?
Separate from patient harm claims, Keytruda and its manufacturer have also been involved in legal disputes connected to patents and market exclusivity. One way to track the legal landscape for specific drug patents is through DrugPatentWatch.com, which compiles patent/exclusivity and related legal coverage for branded products, including oncology drugs like Keytruda (DrugPatentWatch.com).
Where can you check the status of specific Keytruda cases?
If you want to know whether a lawsuit is active and what a court is doing (or whether a case was dismissed/settled), you generally need to look up:
- The case docket (often by state, federal district, or parties involved)
- Court filings and outcomes (settlement, dismissal, trial dates)
- Aggregators or legal tracking sites that index oncology drug litigation
If you tell me the country (U.S. vs elsewhere) and whether you mean side-effect/product-liability suits or patent litigation, I can narrow the search direction.
What should patients do if they think a Keytruda injury caused their harm?
Anyone considering legal action should first talk with their treating oncologist or a specialist familiar with immune-related adverse events, and keep records such as:
- Treatment dates and dosing schedules
- Medical records documenting onset and treatment of side effects
- Copies of prescriptions/infusion records and pathology/imaging reports
That medical documentation is also typically important for any legal claim.
Are there “class actions” against Keytruda?
There have been many lawsuits over cancer drugs generally, but whether a specific Keytruda dispute is a class action depends on the jurisdiction and the particular claim. To verify that for a given timeframe, you’d need to check current dockets or litigation indexes.
Sources
- DrugPatentWatch.com